Olympus Corporation (TSE:7733) will look for acquisitions. Robert White, Chief Executive Officer of Olympus Corporation said, ?And lastly, to complement our innovation-driven growth is to build on our M&A machine through inorganic means through tuck-in acquisitions and partnerships to really complement the robust offering we have". "The other final thing I'd say to your comment, when we think about M&A in med tech, oftentimes, it's about buying R&D. It's about buying a technology that you can add in your bag, develop and you become the better owner of.
And it's rarely you could buy a channel because generally, what we're trying to do in M&A is sit into our existing channel. But this is about driving our weighted average market growth up. So we're going to do acquisitions.
We're going to do partnerships. It's about increase our WAM?.
